CI=confidence interval; HR=hazard ratio; HRadj=adjusted hazard ratio;
Ref=reference level. a Adjusted for positivity to the other HPV genus, age, lifetime number
of sex partners, any sex in last interval, and new sex in last
interval.b Positive for any type of the other HPV genus at
previous visit; corresponds to betapapillomavirus positivity for columns
where alphapapillomavirus incidence is the outcome, and
alphapapillomavirus positivity for columns where betapapillomavirus
incidence is the outcome.
References
1. International Agency for Research on Cancer. Biological agents.
Volume 100 B. A review of human carcinogens. IARC Monogr Eval
Carcinog Risks Hum 2012; 100 (Pt B): 1-441.
2. Gheit T. Mucosal and Cutaneous Human Papillomavirus Infections and
Cancer Biology. Front Oncol 2019; 9 : 355.
3. Agalliu I, Gapstur S, Chen Z, et al. Associations of Oral α-, β-, and
γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer.JAMA Oncology 2016; 2 (5): 599-606.
4. Tommasino M. The biology of beta human papillomaviruses. Virus
Research 2017; 231 : 128-38.
5. Sabol I, Smahelova J, Klozar J, et al. Beta-HPV types in patients
with head and neck pathology and in healthy subjects. Journal of
Clinical Virology 2016; 82 : 159-65.
6. Altamura G, Tommasino M, Borzacchiello G. Cutaneous vs. Mucosal
Tropism: The Papillomavirus Paradigm Comes to an ”and”. Front
Microbiol 2020; 11 : 588663.
7. Bottalico D, Chen Z, Dunne A, et al. The oral cavity contains
abundant known and novel human papillomaviruses from the
Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis2011; 204 (5): 787-92.
8. Moscicki AB, Ma Y, Gheit T, et al. Prevalence and Transmission of
Beta and Gamma Human Papillomavirus in Heterosexual Couples. Open
Forum Infect Dis 2017; 4 (1): ofw216.
9. Nunes EM, Sudenga SL, Gheit T, et al. Diversity of
beta-papillomavirus at anogenital and oral anatomic sites of men: The
HIM Study. Virology 2016; 495 : 33-41.
10. Hampras SS, Rollison DE, Giuliano AR, et al. Prevalence and
Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal
and Cutaneous Sites. The Journal of Infectious Diseases 2017;216 (1): 92-6.
11. Winer RL, Gheit T, Feng Q, et al. Prevalence and Correlates of β–
and γ–Human Papillomavirus Detection in Oral Samples From Mid-Adult
Women. The Journal of Infectious Diseases 2019; 219 (7):
1067-75.
12. Lang Kuhs KA, Gonzalez P, Struijk L, et al. Prevalence of and risk
factors for oral human papillomavirus among young women in Costa Rica.J Infect Dis 2013; 208 (10): 1643-52.
13. Carozzi F, Ronco G, Gillio-Tos A, et al. Concurrent infections with
multiple human papillomavirus (HPV) types in the New Technologies for
Cervical Cancer (NTCC) screening study. Eur J Cancer 2012;48 (11): 1633-7.
14. Chaturvedi AK, Katki HA, Hildesheim A, et al. Human papillomavirus
infection with multiple types: pattern of coinfection and risk of
cervical disease. J Infect Dis 2011; 203 (7): 910-20.
15. Mendez F, Munoz N, Posso H, et al. Cervical coinfection with human
papillomavirus (HPV) types and possible implications for the prevention
of cervical cancer by HPV vaccines. J Infect Dis 2005;192 (7): 1158-65.
16. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL.
Cervical coinfection with human papillomavirus (HPV) types as a
predictor of acquisition and persistence of HPV infection. J
Infect Dis 2001; 184 (12): 1508-17.
17. Tota JE, Ramanakumar AV, Jiang M, et al. Epidemiologic approaches to
evaluating the potential for human papillomavirus type replacement
postvaccination. Am J Epidemiol 2013; 178 (4): 625-34.
18. Tota JE, Struyf F, Merikukka M, et al. Evaluation of Type
Replacement Following HPV16/18 Vaccination: Pooled Analysis of Two
Randomized Trials. J Natl Cancer Inst 2017; 109 (7).
19. Sichero L, El-Zein M, Nunes EM, Ferreira S, Franco EL, Villa LL.
Cervical Infection with Cutaneous Beta and Mucosal Alpha
Papillomaviruses. Cancer Epidemiol Biomarkers Prev 2017;26 (8): 1312-20.
20. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski
G. Design and methods of the Ludwig-McGill longitudinal study of the
natural history of human papillomavirus infection and cervical neoplasia
in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica1999; 6 (4): 223-33.
21. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of
genital human papillomaviruses. J Clin Microbiol 2000;38 (1): 357-61.
22. Gheit T, Billoud G, de Koning MNC, et al. Development of a sensitive
and specific multiplex PCR method combined with DNA microarray primer
extension to detect Betapapillomavirus types. Journal of clinical
microbiology 2007; 45 (8): 2537-44.
23. Berry KJ, Johnston JE, Mielke Jr PW. Permutation methods.WIREs Computational Statistics 2011; 3 (6): 527-42.
24. Lin DY, Wei LJ. The Robust Inference for the Cox Proportional
Hazards Model. Journal of the American Statistical Association1989; 84 (408): 1074-8.
25. Scherpenisse M, Schepp RM, Mollers M, Meijer CJ, Berbers GA, van der
Klis FR. Characteristics of HPV-Specific Antibody Responses Induced by
Infection and Vaccination: Cross-Reactivity, Neutralizing Activity,
Avidity and IgG Subclasses. PLoS One 2013; 8 (9): e74797.
26. Egawa N, Egawa K, Griffin H, Doorbar J. Human Papillomaviruses;
Epithelial Tropisms, and the Development of Neoplasia. Viruses2015; 7 (7): 3863-90.
27. Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B.
Detection of Mucosal Human Papillomavirus Types 6/11 in Cutaneous
Lesions from Transplant Recipients. Journal of Investigative
Dermatology 1993; 101 (3): 286-91.
28. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6:
Epidemiology and transmission dynamics of genital HPV infection.Vaccine 2006; 24, Supplement 3 : S52-S61.
29. Plasmeijer EI, Green AC, de Koning MNC, et al. Transmission of
betapapillomaviruses between domestic partners in an Australian
community. Journal of Clinical Virology 2010; 47 (3):
216-8.
30. Orth G, Jablonska S, Favre M, Croissant O, Jarzabek-Chorzelska M,
Rzesa G. Characterization of two types of human papillomaviruses in
lesions of epidermodysplasia verruciformis. Proc Natl Acad Sci U S
A 1978; 75 (3): 1537-41.
31. Smelov V, Muwonge R, Sokolova O, et al. Beta and gamma human
papillomaviruses in anal and genital sites among men: prevalence and
determinants. Scientific Reports 2018; 8 (1): 8241.